Section 1. Parathyroid - Prognosis of parathyroid function after minimally invasive radioguided parathyroidectomy (MIRP) and percutaneous ethanol injection therapy (PEIT) for primary hyperparathyroidism

Biomedicine and Pharmacotherapy

Volumn 56, Issue SUPPL. 1, 2002, Pages 41-47

  Kakuta, Takatoshi ^a   Suzuki, Yutaka ^a   Tadaki, Futoshi ^a   Uemura, Katsuya ^a   Tanaka, Reika ^a   Tanaka, Shinichi ^a   Kubota, Mitsuhiro ^a   Sakai, Hideto ^a   Kurokawa, Kiyoshi ^a   Saito, Akira ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Minimally invasive radioguided parathyroidectomy; Percutaneous ethanol injection therapy; Primary hyperparathyroidism; Tc 99m sestamibi

Indexed keywords

ALCOHOL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; PARATHYROID FUNCTION; PARATHYROID GLAND; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PATIENT SELECTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; CASE REPORT; HYPERPARATHYROIDISM; INSTRUMENTATION; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; SCINTISCANNING;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROIDECTOMY; PROGNOSIS; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M SESTAMIBI;

EID: 1842865427     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0753-3322(02)00223-8     Document Type: Article

References (23)

1. Chertow B.S., Baylink D.J., Wergedal J.F. Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest. 56:1975;668.
2. Slatopolsky E., Weerts C., Thielan J., Horst R., Harter H., Martin K.J. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest. 74:1984;2136-2143.
3. Hasnain M., Hauncher C., Pegoraro A.A., Arruda J.A., Dunea G. Suppression of hyperparathyroidism by calcitriol therapy. ASAIO J. 45:1999;424-427.
4. Llach F., Hervas J., Cerezo S. The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism. Am J Kidney Dis. 26:1995;841-845.
5. Tsukamoto Y., Nomura M., Marumo F. Pharmacological parathyroidectomy by oral 1,25(OH)2D3 pulse therapy. Nephron. 51:1989;130-131.
6. Kitaoka M., Fukagawa M., Ogata E., Kurokawa K. Reduction of functioning parathyroid mass by ethanol injection in chronic dialysis patients. Kidney Int. 46:1994;1110-1117.
7. Kakuta T., Fukagawa M., Fujisaki T., Hida M., Suzuki H., Sakai H., Kurokawa K., Saitho A. Prognosis of parathyroid function after successful perctaneous ethanol injection therapy guided by color doppler flow mapping in chronic dialysis patients. Am J Kidney Dis. 33:1999;1091-1099.
8. Fukagawa M., Kitaoka M., Tominaga Y., Akizawa T., Kurokawa K. Selective perctaneous ethanol injection therapy (PEIT)of the parathyroid in chronic dialysis patients - the Japanese strategy. Nephrol Dial Transplant. 14:1999;2574-2577.
9. Fukagawa M., Tominaga Y., Kitaoka M., Kakuta T., Kurokawa K. Medical and surgical aspect of parathyroidectomy. Kidney Int. S73:1999;65-69.
10. Kitaoka M., Fukagawa M., Kurokawa K. Direct injections of calcitriol into enlarged parathyroid glands in chronic dialysis patients with severe parathyroid hyperfunction. Nephrology. 1:1995;563-567.
11. Billotey C., Sarfati E., Aurengo A., Duet M., Mundler O., Toubert M.E., Rain J.D., Najean Y. Advantages of SPECT in Technetium-99m-Sestamibi Parathyroid Scintigraphy. J Nucl M. 11:1996;1773-1778.
12. Tibblin S., Bizard J.P., Bondeson A.G., Bonjer J., Bruining H.A., Meier F. Primary hyperparathyroidism due to solitary adenorma: a comparative multicenter study of early and longterm results of different surgical regimens. Eur J Surg. 157:1991;511-515.
13. Kaplan E.L., Yashiro T., Salti G. Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg. 215:1992;300-316.
14. Norman J., Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery. 122:1997;998-1004.
15. Krag D.N., Weaver D.L., Alex C., Fairbank J.T. Surgical resection and radio-localization of the sentinel lymph node in breast cancer using a gammma probe. Surg Oncol. 5:1993;335-340S.
16. Alex J.C., Weaver D.L., Fairbank J.T. Gamma-probe guided lymph node localization in malignant neoplasmas. Surg Oncol. 2:1993;303-308.
17. Thomas S., Reeve M.B., Wendy J., Babidge, Robert F P.arkyn, Anthony J E.dis, Leigh W., Delbridge M.D., Peter G., Guy J., Maddern M.S. Minimally invasive surgery for primary hyperparathyroidism. Arch Surg. 135:2000;481-487.
18. Yamashita H., Noguchi S., Futata T., Mizukoshi T., Uchino S., Watanabe S., Oshima A., Murakami T., Inomata K., Yamashita H. Usefulness of quick intraoperative measurement of intact parathyroid hormone in the surgical management of hyperparathyroidism. Biomed Pharmacother. 54S:2000;108-111.
19. Murphy C., Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 126:1999;1023-1029.
20. Muller-Gartner H- W., Beil F.U., Inge J.D., Greten H. Treatment of primary hyperparathyroidism: perctaneous trancethyroid ethanol installation into a parathyroid adenoma (English abstract). Deutsche Medizinische Wochenschrift. 112:1987;1459-1461.
21. Karstrup S., Holm H.H., Torp-Pedersen S., Hegedus L. Ultrasonically guided perctaneous inactivation of parathyroid tumours. British J Radiol. 60:1987;667-670.
22. Charboneau J.W., Hay I.D., Van Heerden J.A. Persistent primary hyperparathyroidism: successful ultrasound-guided perctaneous ethanol ablation of an occult adenoma. Mayo Clinic Proceedings. 63:1988;913-917.
23. Karstrup S., Lohela P., Apaja-Sarkkinen M., Bogmastars H., Holopeinen O. Non-operative inactivation of a parathyroid tumour in a patients with hypercalcaemic crisis. Acta Medica Scandinavica. 224:1988;187-188.